ARCHIVES

Selumetinib Displays Positive Results, 60% with Stable Disease

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

HHS Reports Some Gains In Reducing Health Disparities

February 8, 2002

Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget.

January 14, 2005

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010

NCI Considering Master Agreements For Cancer Centers

August 2, 1991